Skip to content

Clinical trials

Diabetic Neuropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Clear all

521 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20028
20038
200414
200516
200621
200724
200817
200915
201020
201114
201220
201313
201420
201515
201613
201713
201819
201925
202024
202133
202228
202332
202438
202529
202625

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed331
Unknown status66
Recruiting39
Terminated33
Not yet recruiting22
Withdrawn16
Active, not recruiting11
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Riphah International University24
Eli Lilly and Company12
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.10
UCB Pharma9
Cairo University7
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.7
Aalborg University Hospital6
Pfizer5
Sangamo Therapeutics5
Wyeth is now a wholly owned subsidiary of Pfizer5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies521
Diabetes Mellitus120
Pain63
Neuralgia61
Diabetes Mellitus, Type 259
Diabetic Foot49
Peripheral Nervous System Diseases33
Diabetes Complications31
Diabetes Mellitus, Type 123
Chronic Pain19

Trials

Showing 26 to 50 of 521. Each trial links to its page on Pharma Observatory.

421 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.